Fast progress of the next generation sequencing (NGS) technology has allowed global transcriptional profiling and genome-wide mapping of transcription factor binding sites in various cellular contexts. However, limited number of replicates and high amount of data processing may weaken the significance of the findings. Comparative analyses of independent data sets acquired in the different laboratories would greatly increase the validity of the data. Runx2 is the key transcription factor regulating osteoblast differentiation and bone formation. We performed a comparative analysis of three published Runx2 data sets of chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) analysis in osteoblasts from mouse and human origin. Moreover, we assessed the similarity of the corresponding transcription data of these studies available online. The ChIP-seq data analysis confirmed general features of Runx2 binding, including location at genic vs intergenic regions and abundant Runx2 binding on promoters of the highly expressed genes. We also found high frequency of Runx2 DNA binding without a consensus Runx2 motif at the binding site. Importantly, mouse and human Runx2 showed moderately similar binding patterns in terms of peak-associated closest genes and their associated genomic ontology (GO) pathways. Accordingly, the gene expression profiles were highly similar and osteoblastic phenotype was prominent in the differentiated stage in both species. In conclusion, ChIP-seq method shows good reproducibility in the context of mature osteoblasts, and mouse and human osteoblast models resemble each other closely in Runx2 binding and in gene expression profiles, supporting the use of these models as adequate tools in studying osteoblast differentiation.
A B S T R A C T
Fast progress of the next generation sequencing (NGS) technology has allowed global transcriptional profiling and genome-wide mapping of transcription factor binding sites in various cellular contexts. However, limited number of replicates and high amount of data processing may weaken the significance of the findings. Comparative analyses of independent data sets acquired in the different laboratories would greatly increase the validity of the data. Runx2 is the key transcription factor regulating osteoblast differentiation and bone formation. We performed a comparative analysis of three published Runx2 data sets of chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) analysis in osteoblasts from mouse and human origin. Moreover, we assessed the similarity of the corresponding transcription data of these studies available online. The ChIP-seq data analysis confirmed general features of Runx2 binding, including location at genic vs intergenic regions and abundant Runx2 binding on promoters of the highly expressed genes. We also found high frequency of Runx2 DNA binding without a consensus Runx2 motif at the binding site. Importantly, mouse and human Runx2 showed moderately similar binding patterns in terms of peak-associated closest genes and their associated genomic ontology (GO) pathways. Accordingly, the gene expression profiles were highly similar and osteoblastic phenotype was prominent in the differentiated stage in both species. In conclusion, ChIP-seq method shows good reproducibility in the context of mature osteoblasts, and mouse and human osteoblast models resemble each other closely in Runx2 binding and in gene expression profiles, supporting the use of these models as adequate tools in studying osteoblast differentiation.
Introduction
Fast development and easy availability of high throughput sequencing technologies has allowed rapid accumulation of unbiased genome wide transcription data of several cell and tissue types. Use of chromatin immunoprecipitation combined to NGS sequencing (ChIPseq) in turn has resulted in rapidly accumulating research literature on global transcription factor (TF) binding site mapping of many different cell types (Cao et al., 2010; Handoko et al., 2011; Heinz and Glass, 2012; Lin et al., 2010; Mikkelsen et al., 2010) . Despite the fast progress in the field, there has been relatively few studies utilizing ChIP-seq in cells of the osteogenic lineage, reflecting perhaps the challenging sample material mature bone matrix producing osteoblasts represent. Nevertheless, ChIP-seq analyses of Runx2 (Håkelien et al., 2014; Meyer et al., 2014b; Wu et al., 2014) , C/EBPβ (Meyer et al., 2014b) , VDR and RXR (Meyer et al., 2014a) in osteoblasts have recently been reported. Because of the high amount of data NGS-approaches produce, it is evident that there are several putative candidate genes and mechanisms to be followed by future studies, eventually generating vast amounts of new information on the regulation of osteoblastogenesis. However, the choice of significant candidates to take forward is challenging as the statistical power remains usually low because generally only few replicate samples are included in the individual experiments. Thus the more studies are published and compared to previous data by bioinformatic tools and approaches, the more consistent and reliable information concerning individual genes and pathways can emerge.
Osteoblasts originate from mesenchymal stem cells (MSC) that can give rise to a number of specialized cell types such as adipocytes, myoblasts and chondrocytes. Numerous hormones, growth factors and cytokines regulate the differentiation of an MSC to a specific cell type, driven by a series of transcription factors that control phenotypespecific gene expression. In case of osteoblasts, early bipotent chondroosteogenic progenitor cells express transcription factor SOX9, which is then followed by the expression of Runt family transcription factor (Runx2) and its downstream target Osterix (Osx) in preosteoblasts (Long, 2012) . Runx2 and Osx are both indispensable for osteoblast differentiation as their null mutant mice show total absence of bone and osteoblasts (Ducy, 2000; Nakashima et al., 2002) .
Runx2 belongs to Runt family of transcription factors (Runx1-3) that regulate development and differentiation of many different cell lineages. Runx2 protein contains a conserved 128 amino acid Runt domain, which is responsible for the DNA binding and heterodimerization with CBFβ, that enhances Runx2 binding to DNA (reviewed in Cohen, 2009 ). Importantly, Runx2 can interact with several proteins including co-regulatory proteins and chromatin remodeling factors, leading to complex role in regulating bone specific genes and differentiation. Control of Runx2 expression is complex, and includes epigenetic mechanisms such as miRNAs and several histone modifying enzymes (Huang et al., 2009; Rojas et al., 2015; Yang et al., 2013) . Moreover, Runx2 activity is regulated by several posttranslational modifications such as phosphorylation, acetylation, ubiquitination (reviewed in Jonason et al., 2009 ) and sumoylation .
Mouse MC3T3-E1 cell line is a clonal non-transformed cell line established from new born mouse calvaria (Sudo et al., 1983) and is commonly used for studying osteoblast differentiation in vitro. These cells represent Runx2 positive pre-osteoblasts committed to osteogenic lineage. MC3T3-E1 cells maturate to mineralizing osteoblasts in the presence of standard osteogenic medium containing ascorbic acid and Na-β-glycerophosphate. Of human origin, there are few non-transformed osteoblast cell lines. Thus differentiation of human cells is often investigated by using primary human osteoblasts, immortalized human osteoblast lines (HOBs) or immortalized mesenchymal stem cells (iMSCs). Critical evaluation of the current osteoblast cell culture models is important for further development of reliable and adequate in vitro models, not only for high standard basic research but also for use in pharmaceutical and biomaterial research. Typically, phenotypic assessment of osteoblastic cells include measurement of the expression level of osteoblastic genes (Runx2, Sp7, Ocn, Opn), alkaline phosphatase (ALP) activity and formation of mineralized bone matrix in differentiation cultures. Comparison of different models has often been limited to these few phenotypic properties.
Intriguingly, three papers were published reporting ChIP-seq analyses of genome-wide Runx2 binding in the context of osteoblast differentiation in spring 2014. Two of them, papers from the laboratories of Wesley Pike (Meyer et al., 2014b) and Jane Lian , described Runx2 ChIP-seq analyses of mouse MC3T3-E1 in undifferentiated and differentiated state. Paper of Håkelien and coworkers in turn (Håkelien et al., 2014) , described mapping of Runx2 binding sites in iMSCs (Skarn et al., 2014) differentiated to mature osteoblasts in vitro. In general, there was high degree of similarity in the results reported in these papers, but due to the publishing dates close to each other, the data sets were not directly compared by any of the authors. Our approach was to objectively evaluate and compare the published global gene transcription and Runx2 ChIP-seq data sets collected from these three selected osteoblast studies. Our specific aims were 1) to study differences in the Runx2 genomic occupancy in mouse MC3T3-E1 osteoblasts during their differentiation in data sets produced by two different laboratories, to evaluate the reproducibility of ChIPseq experiments in this model, 2) to examine the interspecies differences in Runx2 binding patterns and target genes between human and mouse samples and 3) to evaluate the similarity of gene expression profiles of undifferentiated and differentiated osteoblasts from mouse and human origin.
Methods

Original data
Summary of the published Runx2 ChIP-seq data and gene expression data used in the study are described in Table I .
Data pre-processing and alignment
Raw ChIP-seq sequencing reads were downloaded from European Nucleotide Archive (ENA) and the reads were subjected to quality control using FastQC software (Andrews, 2010) . Alignments to reference genomes were performed using bowtie2 (version 2.1.0) (Langmead and Salzberg, 2012) , with reads from Meyer et al. and Wu et al. samples aligned to mouse mm9 genome assembly and reads from Håkelien et al. samples aligned to human hg19 genome assembly. All samples were subjected to PCR duplicated removal, after which FastQC quality control was applied again. Alignment statistics of the Bowtie2 alignments are shown in Supplemental Table I . Obtained alignments were inspected visually using Integrative Genomics Viewer (IGV) (Robinson et al., 2011) .
ChIP-seq peak detection and annotation
Peaks were detected from the alignment files by MACS 1.4.2 software (Zhang et al., 2008) using default settings. For Håkelien et al. sample, the peak enrichment was determined relative to a control ChIP with anti-H3 antibody in day 28 iMSC3 cells. For Meyer et al. samples, the peak enrichments were determined relative to a control with IgG antibody in day 0 and day 15 cells. For Wu et al. samples, the peak enrichment was determined relative to sonicated input DNA from day 9 MC3T3-E1 cells. Peaks with p-value < 10 − 10 were used in all downstream analyses. Peaks were annotated to the closest protein coding genes using Bedtools closest (Quinlan and Hall, 2010) tool and gene annotations of the peaks lists sorted by ascending p-value were compared. Because of Meyer et al. and Wu et al. experiments , the overlap of the MACS detected peak regions was also compared directly using R package ChIPSeeker (Yu et al., 2015) , which calculated statistical significance of the peak overlap.
The genomic locations of Runx2 binding peaks were examined using a peak annotation function of HOMER (Hypergeometric Optimization of Motif EnRichment) software . Similar analysis was also performed using Genomic Regions Enrichment of Annotations Tool (GREAT) (McLean et al., 2010) . The analysis was done using default settings that assign a basal regulatory domain of −5 kb and + 1 kb of the transcriptional start site (TSS) and extend it in both directions to the nearest gene's basal regulatory domain but no > 1000 kb distance. The ChIP-seq peak regions were then associated with the genes in whose regulatory domains they laid. GREAT was also used to find GO annotations that are enriched among the genes near the ChIPseq peak regions. For GO enrichment analysis, the assigned gene regulatory domain extended in both directions to the midpoint between the gene's TSS and the nearest gene's TSS but no > 50 kb distance.
Runx2 binding motif scan
Enrichment analysis of conserved Runx2 binding sequence motifs was performed using HOMER software . The analysis was done using default settings and repeat-masked sequence. GSE53982) . The normalized, log2-transformed gene expression values were used for further analyses. The samples used for this analysis were day 0 MC3T3-E1 cells infected with control Scramble-shRNA and the same cells after 9 days of differentiation. Differential expression between the day 0 and day 9 Scr-shRNA cells was determined using R Bioconductor package limma (Ritchie et al., 2015) with obtained pvalues adjusted for multiple testing by Benjamini-Hochberg method (Benjamini and Hochberg, 1995) . Differential expression was defined as significant if the adjusted p-value was below the significance level 0.05 and absolute log2 fold change was at least 1.
Processing of Håkelien et al. RNA-seq data
For Håkelien et al. study, raw RNA-seq read files of day 0 undifferentiated iMSC3 cells and day 28 differentiated iMSC3 cells (two replicates of each) were downloaded from European Nucleotide Archive (ENA) (accession number ERA246830). Quality control of the reads was performed using FastQC software. The quality of all read files was found to be reasonable and no pre-processing was considered necessary. The reads were aligned against human hg19 genome using Bowtie2. Bedtools multicov tool (Quinlan and Hall, 2010) was used for counting the reads aligned to all exonic regions in the genome. The counts from all exons belonging to the same gene were then summarized to get gene-level read counts, and the obtained counts were FPKM (Fragments Per Kilobase of exon per Million fragments mapped) normalized. The non-normalized read counts were used for differential expression analysis by R Bioconductor package DESeq2 (version 1.6.3) (Love et al., 2014) . The obtained p-values were adjusted for multiple testing by Benjamini-Hochberg method. Differential expression was defined as significant if the adjusted p-value was below the significance level 0.05 and absolute log2 fold change was at least 1.
Gene expression data comparison
For comparison of the gene expression profiles from Meyer et al., Wu et al. and Håkelien et al. studies , the gene symbols in Håkelien et al. data were mapped to orthologous mouse gene symbols. Log2-transformed expression values of all samples, scaled to the same range, were hierarchically clustered based on computed Euclidian distance of the samples with complete linkage method.
Further comparison of the gene expression profiles between the three studies utilizing different platforms and two different species was done using R Bioconductor package OrderedList (Yang et al., 2006) with function that detects similarities between two ordered gene lists. The function compares two-ranked list, in this case gene lists ordered by decreasing gene expression value, and a similarity score is assigned based on the number of overlapping genes in the top ranks. Random scores are computed by comparing one list to the randomly shuffled second list, and based on the random scores an empirical p-value can be computed for the observed score. 5000 permutations were used here for estimating the empirical p-values.
Pathway enrichment analyses for the three gene expression data sets were performed by GSEAPreranked, which runs Gene Set Enrichment Analysis (GSEA) (Subramanian et al., 2005 ) against a user-supplied, ranked list of genes. For the analysis, the gene expression lists of all samples containing all the genes were ordered based on the log2 expression values in descending order and mouse gene symbols in Meyer and Wu gene lists were mapped to orthologous human gene symbols. Enrichment was tested for all available KEGG pathway gene sets with number of permutations set to 1000 and enrichment statistic set as classic. For comparison of the pathway enrichment results, the results were filtered using a stringent false discovery rate (FDR) cutoff of 0.01 and ordered by ascending FDR.
Comparison of gene expression to Runx2 occupancy at gene promoters
The relationship between Runx2 binding to gene promoter regions and gene expression was studied using the undifferentiated and differentiated mouse samples from Meyer and Wu studies. Gene expression lists ordered by descending log2 expression values were subset into four groups: (1) Genes with expression level within the highest 20% in undifferentiated cells, (2) genes with expression level within the lowest 20% in undifferentiated cells, (3) genes with expression level within the highest 20% in differentiated cells and (4) genes with expression level within the lowest 20% in differentiated cells. The number of Runx2 ChIP-seq peaks on gene promoter areas in samples at different time points (days 0 and 15 from Meyer study and days 0, 9 and 28 from Wu study) were analyzed and the peak distributions between the four gene groups were compared.
Results and discussion
General comparison of the experimental set up between the studies
The experimental setup for osteoblast differentiation culture was highly similar in all three Runx2 ChIP-seq studies analyzed here, with some variation in the model cell line, in the length of the culture and composition of the osteogenic medium (Table I ). In the two MC3T3-E1 studies, different clones of MC3T3-E1 cells were used, Wu et al. using a later isolated rapidly mineralizing subclone from the original MC3T3-E1 cells (Wang et al., 1999) . iMSC#3 line used in Håkelien et al. study was produced by immortalizing human bone marrow derived stromal cells by retroviral transduction of telomerase reverse transcriptase (TERT). These cells can differentiate to osteoblasts and adipocytes (Skarn et al., 2014) . Osteogenic medium contained ascorbic acid and Na-β-glycerophosphate in all studies, but dexamethasone was used only in the cultures of iMSCs. Osteoblast maturation was verified similarly in all studies by standard methods of ALP, alizarin red and Von Kossa staining to demonstrate lineage commitment and bone nodule formation, respectively.
For Runx2 ChIP-seq, in both MC3T3-E1 studies the first cell stage chosen for analysis were the undifferentiated confluent cells, and the endpoint for sample collection was either 15d (Meyer et al.) or 28d (Wu et al.) after differentiation induction. In addition, Wu et al. included a timepoint representing matrix-producing cells prior to mineralization (9d). In iMSCs, only the 28d differentiated mature osteoblasts were analyzed for Runx2 binding. Two different Runx2 antibodies were used in the studies discussed here, a rabbit polyclonal antibody for MC3T3-E1 cells, and a mouse monoclonal antibody for iMSCs. Notably, the epitope for both these antibodies is in the very same region of Runx2 protein. Despite standardized protocols for some cell types, chromatin immunoprecipitation (ChIP) is a challenging method requiring extensive optimization of sample and antibody-specific conditions including e.g. crosslinking time and temperature, cell lysis, chromatin shearing and washing conditions. Furthermore, special requirements concerning input DNA size and quality have to be met in order to produce good quality sequencing libraries for ChIP-seq. The late-stage osteoblastic cells are tightly surrounded by the collagenous matrix and thus are difficult sample material for ChIP. In the studies discussed here, there was some variability in the ChIP procedures including e.g. cell lysis and sonication conditions, which might have an impact on the sample quality and results, but these aspects are not in the focus in our study.
The method and experimental set up for transcriptional profiling of osteoblastic cells as well as approaches to correlate Runx2 binding site data to transcriptome differed between the studies. Meyer samples had noticeable decrease in quality towards the end of reads, especially in 15d replicate sample 1, but as the majority of bases in reads were of very good quality and the median quality scores were within the very good quality range, no further pre-processing was considered necessary.
Comparison of peak detection results
After duplicate removal the aligned reads were used for peak detection using MACS (Model-Based Analysis of ChIP-seq) (Zhang et al., 2008) . Peak detection results for all samples are shown in Table II . In summary, large amounts of Runx2 peaks were detected in all samples even if more stringent p-value cutoff of 10 − 10 was used.
Noticeable is the reduction in peak count in Meyer day 15 replicate 1 sample after more stringent cutoff was applied, in accordance with the lower quality of reads that was observed in quality control. A simple quality metrics FrIP for ChIP-seq data is also shown in Table II . The recommendation for this metrics is ≥ 1% by ENCODE consortium for a successful experiment (Landt et al., 2012) , and the scores of all samples exceed this limit. Peaks with p-value < 10 − 10 were used in all downstream analyses. In the published paper Meyer et al. reported contraction of the Runx2 cistrome during differentiation, demonstrated by 12,674 and 6272 genomic regions with Runx2 binding in the early and late state osteoblasts, respectively (Meyer et al., 2014b) . Wu et al. in turn reported approximately 25,000 significantly enriched regions at day 0 and an increase in the number of Runx2 bound sites in later timepoints, yielding up to 80,000 Runx2 enriched regions in MC3T3-E1 cells . In the re-analysis performed here, we did not observe as high variation in the detected peak numbers between the two MC3T3-E1 studies as reported previously, suggesting the difference in the peak numbers between the original studies to be related to the data analysis rather than to a major difference in Runx2 binding abundance (Table  II) . In our analysis, Wu et al. samples showed increased number of Runx2 peaks in D9 and D28 samples compared to D0 sample, whereas peak number in Meyer et al. study stayed constant between the timepoints (when excluding the one D15 replicate of lower quality) (Table II) . In the original papers, there was a minor difference in Runx2 protein expression pattern, the protein level being constant in Meyer's paper but showing increase in Wu's paper, which is in accordance with the dynamics in Runx2 peak numbers observed. In iMSC#3 cells, we found large number of Runx2 peaks (80061) and very high FRiP value (48,7%), suggesting a successful ChIP experiment. However, Håkelien et al. reported only 9549 peaks in the 50 kb region of closest 5′ gene end, suggesting major differences in the analysis methods and/or filtering parameters used. Thus, we will not further compare our iMSC analysis results to the published results, but use our de novo analysis results to the analysis of mouse MC3T3-E1 cells in order to perform inter-species comparisons.
Comparison of annotated genes close to Runx2 peaks
Peaks were annotated to the closest protein coding genes using bedtools closest tool (Quinlan and Hall, 2010) . Annotated peak lists were sorted by ascending p-value so that the most enriched peaks of each sample could be compared. To allow cross-species comparisons, the human gene symbols were translated to orthologous mouse gene symbols. Venn diagrams of the unique and common genes annotated to the top 5000 most enriched peaks are shown in Fig. 1 Supplementary Fig. 1 ). In conclusion, the comparisons between the differentiation stages suggest that Runx2 constitutively occupies more than half of the total Runx2 bound genes regardless of the differentiation stage.
Comparison of peak annotations of human differentiated iMSC3 samples to differentiated mouse MC3T3-E1 samples from both Meyer and Wu shows overlaps of 39% and 43% in top 5000 annotated genes, respectively (Fig. 1C,D) . The overlap percentages are, as could be expected, lower than those of within-species comparisons and in line with previous findings that have shown that most TF binding events are species-specific (Wilson and Odom, 2009 ). However, altogether 1344 genes from top 5000 annotated genes were in common for all samples in the last differentiation time point, suggesting substantial similarity in Runx2 peak associated genes between the species and experiments. This could suggest that these genes are especially important for the Runx2-mediated regulation of osteoblast differentiation.
For Meyer and Wu mouse samples it was possible to compare directly the overlap of the peak regions. The results indicate that peaks in undifferentiated and differentiated mouse samples have a highly significant overlap both within and between the studies (Table III) . For example, when comparing undifferentiated cells to differentiated cells in each study, 88% (Wu et al. study) and 67% (Meyer et al. study) of the peak regions at day 0 were present also in differentiated cells. Moreover, at day 0, 88% of peaks observed in Wu et al. study are detected also in Meyer et al. day 0 sample. In the differentiated cells, corresponding overlap was 50%, possibly related to the variable time course and the different MC3T3-E1 cell clones used in the two studies as well as the challenging sample material at the late time points. Importantly, these results indicate that ChIP-seq experiments in MC3T3-E1 cells show relatively high reproducibility in two individual studies and again that majority of the Runx2 bound sites are constant during differentiation.
Comparison of genomic locations of Runx2 peaks
The genomic locations of Runx2 binding peaks were examined using a peak annotation function of HOMER software. The distributions of Runx2 peaks are displayed in Fig. 2A . In accordance with the original articles, the vast majority of Runx2 binding occurred at intergenic and intronic regions. The greatest variation between the differentiation stages was in Runx2 occupancy at promoters, with higher occupancy in Fig. 2 . Genome-wide profile of Runx2 occupancy. A-B) Distribution of Runx2 binding peaks across mouse and human genomes were classified into eight categories: Exon, Intron, Promoter (− 1 kb to + 100 bp from transcription start site), TTS region (−100 bp to +1 kb from transcription termination site), 5′ UTR exon, 3′ UTR exon, Intergenic region and other regions. Peak distributions in all samples are plotted by peak number (A) and by the percentage of total peaks (B). C-E) Analysis of the Runx2 peak association to genomic regions using GREAT at the last time point in each of the three studies. In the analysis, a basal gene regulatory domain of − 5 kb and 1 kb of the TSS was assigned and extended in both directions to the nearest gene's basal regulatory domain with a maximum distance of 1000 kb. Runx2 peak regions where then associated with the genes in whose regulatory domains they are located. In addition, GO Biological Process term enrichment analysis of the last time point samples in each study using GREAT is presented (right panels). In this analysis, the assigned gene regulatory domain extended in both directions to the midpoint between the gene's TSS and the nearest gene's TSS with a maximum distance of 50 kb. The figure shows the most enriched GO terms among the genes near the ChIP-seq peak regions.
undifferentiated cells in both MC3T3-E1 studies ( Fig. 2A,B , Table IV ). Similar analysis was performed using GREAT software, which finds GO annotations that are enriched among the genes near the ChIP-seq peak regions. Graphs showing the distance between peak regions and their putatively regulated genes as well as the most enriched biological process GO terms obtained from GREAT analysis for differentiated cells are shown in Fig. 2C -E. In summary, the pattern of Runx2 peak enrichment was very similar between the experiments, showing clear enrichment of Runx2 binding in the vicinity of TSS. Among enriched GO terms in biological processes category there were both common and closely related terms and some unique pathways, reflecting the overlap of the annotated genes close to the peaks (Fig. 1) . The enriched terms such as RNA related processes, cell-and tissue morphology related pathways, resembled closely the published data of each report. The minor differences in the term enrichments to the original articles results might be due to differences in performing the analysis, for example Wu et al. used time-dependent dynamic clusters of Runx2 peaks, whereas in our analysis all Runx2 peaks at certain time point were included.
Runx2 binding motif enrichment in Runx2 peak regions
ChIP-seq peaks were scanned for conserved TF sequence motifs using HOMER software. HOMER includes a motif database that is mostly based on the analysis of public ChIP-Seq data sets . The full tables of the results of the motif scan are presented upon request. In mouse samples, the most significantly enriched motifs were three motifs that have been experimentally associated with binding of Table V . These motifs were present in altogether 36-54% of Runx2 peaks in all MC3T3-E1 samples (Table VI) . In the motif scan, two mismatches to the consensus sequence were allowed in the analysis, leading to inclusion of high number of different variant motifs as Runx2 motifs, referred hereafter altogether as Runx2 motif. Accordingly, significant enrichment of a classic Runx2 binding core motif TGTGGT at the Runx2-bound regions was reported in both MC3T3-E1 studies previously. In iMSCs on the other hand, the known Runx2 motifs were found in only 14,4% of the peaks and the motifs ranked as most significantly enriched were for AP1 and ETS family transcription factors. Thus, in iMSC sample, although having the highest number of peaks left after quality filtering, only minority of these peaks appear to contain Runx2 binding motifs. This may indicate that the Håkelien et al. sample contains more false positives and would require more stringent filtering of the detected peaks, or that the Runx2 motif in human DNA is highly variable and was not recognized in our analysis.
RUNX-family of transcription factors ((A/T/C)TGTGGTT(A/T); (G/T) (T/C)TGTGGTTT; CTGTGGTTT(G/C))), presented in
Interestingly, the motif scan revealed also other significantly enriched TF consensus motifs at Runx2 peak regions. Secondary binding motifs may suggest for example protein-protein interactions, by which Runx2 is recruited to sites without Runx2 binding motif, or possible co-operative binding and/or collaboration of Runx2 with other transcription factors at the same region. When comparing the top 20 enriched motifs in each sample, there were 9 common motifs found in all samples (Table VII) . Most of these were related to AP-1 family proteins including Atf3, Fra1 and Jun-AP1 motif. These consensus motifs are found at high frequency in the genome and are involved in a wide variety of cellular processes.
Interestingly, another significantly enriched motif in every data set was for TEAD family factors and especially for TEAD4, present in 9-17% of Runx2 peaks in mouse and in 10% of peaks of human samples. In Håkelien et al. original article, TEAD2 motif enrichment was reported in regions enriched for promoter and enhancer related histone modifications H3K4me3, H3K9ac and H3K27ac at the end of differentiation, and its knockdown was then further shown to cause impaired mineralization in vitro.
TEAD family of transcription factors are effectors in the Hippo signaling pathway regulating organ size by controlling cell proliferation and apoptosis (Landin-Malt et al., 2016) . TEADs form a complex with Yes-associated protein (YAP) or its paralog transcriptional co-activator with PDZ binding motif (TAZ) to activate target gene expression. Both YAP and TAZ in turn interact also with Runx2 (Hong et al., 2005; Zaidi et al., 2004) and they have been implicated in regulating MSC differentiation (Hong et al., 2005) and in Wnt and BMP signaling (Varelas, 2014) . Very recently, stabilization of TAZ-Runx2 complex was shown to play an important role in promoting osteoblastogenesis (Matsumoto et al., 2016) . When inspecting Runx2 peaks with the TEAD4 motif more closely, approximately half of the TEAD4 motif containing peaks contained also Runx2 motif in mouse samples, comprising 4-10% of all Runx2 peaks, whereas in human iMSCs only 1,5% of total Runx2 peaks contained both motifs (Supplemental Table  II ). These results suggest that TEAD4 and Runx2 interaction might take place at least in part of the Runx2 occupied regions through a common protein complex (TEAD4 motif only regions) or through collaborative binding via putative nearby DNA binding motifs (co-presence of TEAD4 and Runx2 motifs). Given the emerging literature of the importance of TEAD/TAZ/YAP proteins in osteogenesis (Matsumoto et al., 2016; Tang et al., 2016) , role of TEAD-Runx2 interaction and protein complex in osteoblasts would be highly interesting target for future studies.
Runx2 occupancy at the promoter regions
Runx2 binding sites where inspected in more detail at promoter regions, which are more likely to be conserved across species than the distal enhancer sites (Cheng et al., 2014) . The promoter sequences (2 kb upstream from TSS) of all orthologous pairs of human and mouse genes were retrieved and annotated for the nearest ChIP-seq peaks in mouse and human samples. The results of the extensive analysis are provided in Supplemental Table III . The promoter coordinates, nearest peak region's coordinates, and the distance of the peak from the promoter are shown for all genes together with information indicating the number of samples, in which Runx2 peaks were found. In addition, the number of consensus Runx2 motifs found at each peak region is reported in the table. If the peak distance from the promoter region is annotated as 0, it means that the peak is overlapping with the promoter. Gene expression data from the studies (described in detail in Section 3.3.) have been integrated into the table as well. Another view of the data is presented in Supplemental Table IV , which shows the presence of Runx2 at gene promoters at different time points together with the related gene expression data, offering possibility to assess the dynamics of Runx2 binding at individual gene promoters between the studies. These tables with annotated gene information can be used as a resource, when exploring possible Runx2 binding in the vicinity of any gene of interest. For example, by filtering and organizing columns in Tables SIII and SIV, various groups of genes of interest can be selected based on their Runx2 binding properties and expression profiles.
We next searched for genes that had Runx2 peaks near the promoter regions in all 7 mouse samples indicating high confidence of constitutive Runx2 binding during differentiation using the Supplemental Table  IV . These genes and their promoters had several common features. First, most of these Runx2-occupied genes were relatively highly expressed but only minority (11%) of them contained Runx2 motifs in the peak regions. Similarly, the corresponding human orthologues of these genes had nearby Runx2 peaks, were expressed and showed low frequency of Runx2 consensus motifs. These observations suggest either Runx2 motif is highly variant on these sites, or that Runx2 may be recruited to many regions by other mechanisms than by direct binding to Runx2 motifs in the DNA. Whether Runx2 binding is required for the transcription of these genes is not clear. Interestingly, in the study of Wu et al. only 159 genes responded to Runx2 knockdown during differentiation, which is far less than genes occupied by Runx2. As Runx2 has also genomeorganizing capabilities (Lian et al., 2003) , it may well be that on these other genes Runx2 modifies the genomic landscape rather than directly regulates gene expression.
Nevertheless, Wu et al. reported more Runx2 peaks in the shRunx2 downregulated genes (thus Runx2 upregulated genes) compared to shRunx2 upregulated or nonresponsive genes. Accordingly, when we inspected the abundance of Runx2 peaks and Runx2 motifs close to the shRunx2 responsive/unresponsive genes (Table VIII) , the shRunx2 downregulated genes contained indeed more Runx2 peaks per gene, and especially more Runx2 motif containing peaks per gene (average 3,1/gene) than the upregulated or nonresponsive genes (average 1,1/ gene), supporting the high frequency of Runx2 motifs together with Runx2 binding to be an strong indicator of direct transcriptional activation by Runx2.
Gene expression data
The gene expression analysis was performed by using different platforms and experimental setups as described in Section 3.1., resulting in data provided in different formats in on-line repositories. For the comparisons, all gene expression data sets were processed to produce normalized log2-transformed expression values for the expressed genes. Atf3  RUNX1  RUNX1  RUNX1  RUNX1  RUNX1  BATF  RUNX2  RUNX2  RUNX2  RUNX2  RUNX2  Fra1  RUNX-AML  RUNX-AML  RUNX-AML  RUNX-AML  RUNX-AML  AP-1  TEAD4  TEAD4  Fra1  Fra1  Fra1  Fosl2  TEAD  TEAD Fig. 3 . The heat map clearly shows that samples coming from the same study are most similar to each other based on their gene expression profiles, regardless of the differentiation stage of the cells. Thus, the effects caused by differences in the cell clones or other technical aspects between the studies mask the effect of differentiation on the overall gene expression profiles even in the samples from the same species. The finding of only moderate changes in gene expression profiles between the differentiation states might also reflect the fact that MC3T3-E1 cells are already committed to the osteogenic lineage and the most striking changes in gene expression from the stem cell stage to preosteoblasts have already passed. Nevertheless, these results demonstrate that the widely distributed cell lines may exhibit clonal shift resulting in phenotypic/epigenetic/transcriptomic changes over time, and highlight the importance of critical evaluation of results obtained from a single cell line.
Similarity of gene expression profiles
In order to assess the similarity of the gene expression profiles between the samples from different studies using different platforms and even from different species, R Bioconductor package OrderedList (Yang et al., 2006) was utilized for detecting similarities of two ordered gene lists. In short, two ranked lists (according to the mRNA expression level) were compared and a similarity score was assigned based on the number of overlapping genes in the top ranks. Plots of overlapping genes in Meyer et al. and Wu et al. day 0 top or bottom ranked gene expression lists are shown in Fig. 4A-B , where the overlap size increases if the gene in top ranks of list 1 is found within the top ranks of list 2. The observed overlap was compared to the expected overlap derived from a hypergeometric distribution. The significance of the similarity of the lists within top 1000 genes was very high (Fig. 4B) , with p-value of 0. Within top 100 genes the similarity was lower but still highly significant (Fig. 4A) , with p-value 0,0026. Number of common genes in these top 100 and top 1000 expressed gene lists was 15 and 271, respectively. Similar comparisons for undifferentiated human osteo- blasts (Håkelien et al. day 0) and undifferentiated mouse osteoblasts (Meyer et al. day 0) and for differentiated human osteoblasts (Håkelien et al. day 28) and differentiated mouse osteoblasts (Meyer et al. day 15) are shown in Fig. 4C-F . In summary, all gene expression lists appeared highly similar within the highly expressed, top-ranked genes. The overlaps of the bottom ranked genes were close to random overlap, which was expected as the genes at the bottom of the ranked lists are mostly very lowly or not at all expressed and appear as random noise. The similarity of the gene expression profiles was also evaluated based on the pathway enrichment analysis of the gene expression profiles. For the analysis, the gene expression lists of all samples containing all the genes were ordered based on the log2 expression values in descending order, and mouse gene symbols in Meyer et al. and Wu et al. gene lists were translated to orthologous human gene symbols. (Fig. 5A) and 58% of the pathways in differentiated samples from the same studies overlapping (Fig. 5B) (Fig. 5C-F) . Interestingly, for undifferentiated samples from Meyer et al. and Håkelien et al. samples, the overlap is relatively high, 62%, suggesting the phenotype of the cells to resemble each other closely although MC3T3-E1 represent committed pre-osteoblasts and iMSCs multipotent stem cells. Comparison of differentiated human osteoblasts to differentiated mouse osteoblasts from Meyer's and Wu's studies show also a consistent overlap of 58% in the 30 most significantly enriched pathways in both comparisons. However, when evaluating the similarity of gene expression profiles it is important to keep in mind that transcriptomes of different tissues consist of a large amount of ubiquitously expressed genes. For example, in a RNA-seq analysis of multiple tissues, of the 11,000-13,000 expressed genes > 40% were shown to be expressed in all tissue and cell types, and moreover that their mRNAs represented 75% of the total mRNA quantity expressed in any given cell type, suggesting cell type specific mRNAs to account only the minority in a mRNA pool (Ramsköld et al., 2009 ).
Correlation of Runx2 promoter occupancy and gene expression in MC3T3-E1 cells
Mouse samples from Meyer et al. and Wu et al. studies were then compared for Runx2 binding to promoter regions of genes that are expressed at high or low levels in undifferentiated and differentiated cells. For this purpose, gene expression lists were ordered by decreasing order of log2 expression level. We then analyzed Runx2 occupancy at promoters (− 2 − 0 kb from TSS) of 20% of the highest and lowest expressed genes at each time point. Bar graphs showing the number of unique and common Runx2 occupied genes in the 20% highest/lowest expressed gene groups between the timepoints in each study are shown in Fig. 6 . Consistently in both studies, Runx2 binding was remarkably more abundant in promoters of highly expressed gene than of genes with low expression. The pattern of Runx2 promoter peak distribution was almost identical in undifferentiated and differentiated cells, which is in accordance with the observation that the gene expression profiles were highly similar at the two differentiation stages in both studies. Notable, more than half of the most highly expressed genes in both Meyer et al. and Wu et al. studies contained Runx2 peaks at their promoters, emphasizing that Runx2 has an important role in maintaining the phenotype and gene expression profile of osteoblastic cells. Based on our analysis, the minor difference between the studies was that there were very few unique Runx2 peaks in undifferentiated cells in Wu et al. study, while there was a significant number of unique peaks in day 0 sample in Meyer et al. study.
In Meyer's study close to half of the 721 DE transcripts between the differentiation stages overlapped with Runx2 peak-associated genes either at POB, OB or at both states. Similarly to our results, when they looked at the 20% most highly or lowly expressed genes, they found the most highly expressed genes in both POBs and OBs to be significantly more enriched with Runx2 peaks. In the original article of Wu et al. in turn reported 159 Runx2 responsive genes in a Runx2 shRNA knockdown experiment of 9d differentiated cells. Most of these shRunx2 downregulated genes showed higher Runx2 enrichment close to the TSS than the upregulated ones, which is in line with our observation that the promoters of highly expressed genes are more occupied by Runx2 than the promoters of genes with low expression. Despite the abundance of Runx2 at gene promoters of highly expressed genes, the number of shRunx2 responsive genes seems to be surprisingly low, suggesting other than direct transcriptional effects of Runx2 binding at most of the promoters. Accordingly, in SaOS osteosarcoma cells abundant Runx2 occupancy at gene promoters was previously demonstrated not to be directly correlated to gene expression nor highly Runx2 occupied genes to be responsive to Runx2 depletion (van der Deen et al., 2012) . Interestingly, in our analysis, a consensus Runx2 binding motif was present only in a minority of the promoter areas occupied by Runx2 (shown also in Supplemental Tables III and IV and discussed in Section 3.2.6), further suggesting collaboration or coregulation with other proteins at these sites (Fig. 6 ).
Conclusions
We performed a small-scale meta-analysis of three published osteoblast Runx2 ChIP-seq data sets of mouse and human origin and in addition evaluated the similarity of their corresponding gene transcription data produced by DNA microarrays or RNA-seq. From the technical point of view, both ChIP-seq data and gene expression data from two different MC3T3-E1 clones showed high degree of similarity, suggesting that overall ChIP-seq assay even in these difficult samples can produce reliable and reproducible data. Moreover, our data demonstrates relatively small overall variation in the phenotypes of these cells. By using similar data processing and analysis pipeline to all data sets, we could confirm some common features of Runx2 binding reported in the original studies. First, while Runx2 binding is enriched in the genic context including e.g. approximately 20% of all binding sites at gene promoters, relatively high proportion of Runx2 peaks remain in the intergenic genomic locations. Secondly, a substantial portion of Runx2-occupied genomic regions do not contain consensus Runx2 DNA binding motifs, suggesting the Runx2 motif to exhibit even greater variability than previously shown, or that other DNA binding mechanisms and/or collaborative binding with other protein complexes may play an important role in determining Runx2 occupancy at specific sites. Third, majority of the highly expressed genes in osteoblasts contain bound Runx2 at their promoters, however the regulatory role of Runx2 at these sites remain open. In addition, we evaluated interspecies differences in Runx2 binding patterns in mouse and human samples. In general, Runx2 binding features in the human sample resembled closely the observations from mouse data. Importantly, when mouse and human Runx2 binding at the vicinity of genes was compared, approximately 40% of the genes showing highest enrichment of Runx2 were in common, suggesting high degree of similarity and thus conservation of Runx2 regulated mechanisms between the species.
Regarding gene expression profiling, mouse MC3T3-E1 cells showed similar gene expression profiles in two different laboratories, but the differentiation stage caused only minor changes in the global expression profile in these cells. Moreover, human iMSCs and mouse MC3T3-E1 gene expression profiles and enriched pathways showed substantial similarity, suggesting these cell models to represent osteoblastic phenotype in a similar manner. However, there were also some unique cellular processes activated in each sample, highlighting the limitations of in vitro models and importance of studying and reproducing biologically relevant observations in more than one cell line. Finally, our study demonstrates that objective re-analysis and pooling of independent genome-wide NGS datasets is very important to validate the findings of individual studies. With a higher number of replicates and larger pool of data this type of analyses also allow for identification of the true target promoters/genes and pathways and mechanisms of transcriptional regulation that might be otherwise missed.
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.gene.2017.05.028.
